Comparative Testing of Peripheral Blood and Bone Marrow for BCR-ABL Transcripts in Patients Post Allogeneic Bone Marrow Transplantation and During Interferon Treatment for Chronic Myeloid Leukemia

References

• Clift R, Appelbaum F, Thomas E. Bone Marrow Transplantation for chronic myelogenous leukemia. Blood 1994; 83: 2752–2753
   PubMed Web of Science ®Google Scholar
• Rowley J D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quina‐crine fluorescence and Giemsa staining. Nature 1973; 243: 290–293
   PubMed Web of Science ®Google Scholar
• Davis R L, Konopka J B, Witte O N. Activation of the c‐abl oncogene by viral transduction or chromosomal trans‐location generates altered c‐abl proteins with similar in vitro kinase properties. Mol Cell Biol 1985; 5: 204–213
   PubMed Web of Science ®Google Scholar
• Daley G Q, Van Etten R A, Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of Philadelphia chromosome. Science 1990; 247: 824–830
   PubMed Web of Science ®Google Scholar
• Dewald G W, Juneau A L, Schad C R, Tefferi A. Cyto‐genetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia. Cancer Genet Cytogenet 1997; 94: 59–66
   PubMed Web of Science ®Google Scholar
• Xu W M, Piao X H, Addy L, et al. Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia. Bone Marrow Transplant 1994; 14: 299–306
   PubMed Web of Science ®Google Scholar
• Santini V, Zoccolante A, Bosi A, et al. Detection of bcr/abl transcripts by RT‐PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving alloge‐neic bone marrow transplantation. Hematologica 1996; 81: 201–207
   PubMed Web of Science ®Google Scholar
• Zhang J G, Lin F, Chase A, et al. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation. Blood 1996; 87: 2588–93
   PubMed Web of Science ®Google Scholar
• Hochhaus A, Reiter A, Skladny H, et al. Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy. Recent Results Cancer Res 1998; 144: 36–45
   PubMedGoogle Scholar
• Tefferi A, Litzow M R, Noel P, Dewald G W. Chronic granulocytic leukemia: recent information on pathogenesis, diagnosis and disease monitoring. Mayo Clin Proc 1997; 72: 445–52
   PubMed Web of Science ®Google Scholar
• Dewald G W, Juneau A L, Schad C R, Tefferi A. Cyto‐genetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia. Cancer Genet Cytogenet 1997; 94: 59–66
   PubMed Web of Science ®Google Scholar
• Radich J P, Gehly G, Gooley T, et al. Polymerase chain reaction detection of the BCR‐ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995; 85: 2632–8
   PubMed Web of Science ®Google Scholar
• Bianchi C, Cairoli R, Marenco P, et al. Detection by polymerase chain reaction of BCR/ABL transcripts in myelo‐proliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukemia patients after bone marrow transplantation. European Journal of Cancer 1995; 31: 197–201
   Web of Science ®Google Scholar
• DeIage R, Soiffer R J, Dear K, et al. Clinical significance of bcr‐abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood 1991; 78: 2759–67
   PubMed Web of Science ®Google Scholar
• Hochhaus A, Lin F, Reiter A, et al. Quantification of residual disease in chronic myelogenous leukemia patients on interferon‐a therapy by competitive polymerase chain reaction. Blood 1996; 87: 1549–55
   PubMed Web of Science ®Google Scholar
• Feng L, Goldman J M, Cross N CP. A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukemia. Br J Hematol 1994; 86: 683–685
   PubMed Web of Science ®Google Scholar
• Paldi‐Hark P, Foldi J. Experiences with the determination of chimera bcr‐abl messages in bone marrow and peripheral blood samples in chronic myeloid leukemia. Br J Hematol 1995; 89: 684–685
   PubMed Web of Science ®Google Scholar
• Seong D, Thall P, Kantarjian H M, et al. Philadelphia chromosome positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow. Clin Cancer Research 1998; 4: 861–867
   PubMed Web of Science ®Google Scholar
• Chomoczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate‐phenol‐chlo‐roform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Rassool F, Martiat P, Taj A, et al. Interstitial insertion of varying amounts of ABL‐containing genetic material into chromosome 22 in Ph‐negative CML. Leukemia 1990; 4: 273–277
   PubMed Web of Science ®Google Scholar
• Maniatis T, Fritsch E T, Sambrook J. Molecular cloning. Clodspring Harbour Laboratory. 1980; 217
   Google Scholar
• Heisterkamp N, Stephenson J R, Groffen J, et al. Localization of the c‐ABL oncogene adjacent to a transloca‐tion breakpoint in chronic myelocytic leukemia. Nature 1983; 306: 239–242
   PubMed Web of Science ®Google Scholar
• Heisterkamp N, Stam K, Groffen J, et al. Structural organization of the BCR gene and its role in the Ph' translo‐cation. Nature 1985; 316: 758–761
   PubMed Web of Science ®Google Scholar
• Shaw C P. Disease prevention and health promotion. Public health and preventive medicine in Canada. University of Toronto press. 1992; 62–75
   Google Scholar
• Fleiss J L. The measurement of inter rater agreement. Statistical methods for rates and proportions. John Wiley. & sons, Inc. 1981; 212–236
   Google Scholar
• Lange W, Snyder D S, Castro R. Detection by enzymatic amplification of BCR‐ABL mRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia. Blood 1989; 73: 1735–41
   PubMed Web of Science ®Google Scholar
• Roth M S, Antin J H, Bingham E L. Detection of Philadelphia chromosome positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 1989; 74: 882–885
   PubMed Web of Science ®Google Scholar
• Kawaishi K, Kimura A, Katoh O, et al. Decreased L‐selectin expression in CD34‐ositive cells from patients with chronic myeloid leukemia. Br J Hematol 1996; 93: 367–74
   PubMed Web of Science ®Google Scholar